Does OLUTASIDENIB Cause Differentiation syndrome? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Differentiation syndrome have been filed in association with OLUTASIDENIB (REZLIDHIA). This represents 2.4% of all adverse event reports for OLUTASIDENIB.
5
Reports of Differentiation syndrome with OLUTASIDENIB
2.4%
of all OLUTASIDENIB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Differentiation syndrome From OLUTASIDENIB?
Of the 5 reports, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Differentiation syndrome Listed in the Official Label?
Yes, Differentiation syndrome is listed as a known adverse reaction in the official FDA drug label for OLUTASIDENIB.
What Other Side Effects Does OLUTASIDENIB Cause?
Off label use (59)
Hospitalisation (27)
Death (24)
Nausea (23)
Fatigue (21)
Product dose omission issue (19)
Product prescribing issue (15)
Constipation (14)
Transfusion (11)
Pneumonia (9)
What Other Drugs Cause Differentiation syndrome?
TRETINOIN (251)
ARSENIC TRIOXIDE (180)
ENASIDENIB (102)
GILTERITINIB (80)
IVOSIDENIB (80)
AZACITIDINE (50)
HYDROXYUREA (41)
DEXAMETHASONE (38)
CYTARABINE (33)
PREDNISONE (25)
Which OLUTASIDENIB Alternatives Have Lower Differentiation syndrome Risk?
OLUTASIDENIB vs OMACETAXINE MEPESUCCINATE
OLUTASIDENIB vs OMADACYCLINE
OLUTASIDENIB vs OMALIZUMAB
OLUTASIDENIB vs OMAVELOXOLONE
OLUTASIDENIB vs OMBITASVIR